Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Tenax Therapeutics
Sort By
Newest First
1 / 1
1 / 1
Pricing
Tenax Therapeutics Announces Pricing of $10 Million Underwritten Offering
Tenax Therapeutics
PA3254
Dec 13, 2018
Phase 2 Trial
Tenax Therapeutics Announces Study Design for Phase 2 Trial of Levosimendan in PH-HFpEF Patients
Tenax Therapeutics
PR-M06-18-NI-027
Jun 08, 2018
